
Genomics and startups. Previously @Phosphorus, @Recombine. I believe we can improve healthcare with genomics. š¦ š§¬š³āš
New York, NY
Joined July 2009
- Tweets2.2K
- Following2K
- Followers1.2K
- Likes2.2K
Alex Bisignano retweeted
They lied about the virus, about their population size, about their GDP growth, why are they NOT going to lie about the amount and type of GPUs they used?
Alex Bisignano retweeted
Digital health founder showing the doctor how to log in for the fifth time so they can use the product
Alex Bisignano retweeted
Whoa, I just realized that raising a kid is basically 18 years of prompt engineering š¤Æ
Alex Bisignano retweeted
LDL-p vs ApoB. Both outperform LDL-c and perhaps non-HDL-c in risk assessment especially on statins. Although, I am big fan of ApoB, I often prefer LDL-p because discordance from LDL-c is more evident. This is a good example in a patient with premature ASCVD on a statin.
Alex Bisignano retweeted
I'm thrilled to announce the launch of Downshift, the world's first decelerator program tailored for high performers in transition.
Downshift is a transformative, 8-week journey aimed at fostering presence, self-discovery, and renewal.
Designed for diverse professionals who've tasted success or reached the top, yet long for deeper significance, our Downshifters include founders recovering from their last startup, executives searching for fulfillment beyond titles, athletes leaving the game behind, creators seeking a new stage, and investors pondering what constitutes a truly meaningful life.
Our program weaves together a rich tapestry of activities, including an in-person retreat to establish a solid foundation, weekly lectures and discussions, tailored one-on-one coaching sessions with me, and much more.
All of this unfolds within a nurturing and intentional community, limited to just 12 Downshifters, to ensure a deep sense of belonging and meaningful relationships.
Our Downshifters will emerge with a diverse set of tools and abilities to mindfully manage life's changes and craft a life in true alignment with their authentic selves and core values.
More than a program, Downshift is a philosophy. It challenges the prevailing culture of hustle, stress, and perpetual growth dominant in sectors like technology and finance. We advocate for a more balanced approach, one that values patience, introspection, and self-compassion.
At the heart of Downshift lies a deep commitment to intentionally slowing down. Rather than pushing for rapid acceleration, our program emphasizes the inner work essential for navigating life's transitions with clarity, intention, and courage.
We fundamentally believe that slowing down or taking a pause doesnāt mean decelerating indefinitely or giving up your ambition. Numerous high performers have decelerated and are flourishing on their unique paths.
Our method is founded on the belief that genuine transformation arises from deep engagement with oneself and the surrounding world, ensuring wisdom is cultivated with each step forward.
My journeyāas both a mentor and a seekerāhas taught me that meaningful personal and professional evolution cannot be forced or expedited. True transformation demands space, time, introspection, and support.
Inspired by my personal journey from venture capital to coaching, Downshift reflects the program, support, and community I longed for during my five-year transition. It is the culmination of my life's work, born out of thousands of hours of experience, learning, and exploration.
If you're at a crossroads, feeling uncertain, or navigating a transition, Downshift could be precisely what you need to traverse the abyss toward a future that respects your true essence.
Our journey kicks off on Wednesday, April 17th, and wraps up on Saturday, June 15th. We are now accepting applications.
Learn more about the program here. We'd be delighted to welcome and support you on your journey.
downshift.me
Alex Bisignano retweeted
One of the biggest missed opportunities in U.S. healthcare is that as a society, we could be investing in better outcomes for everyone, which would save money in the long term - but often doesnāt happen because it costs more in the short term.
Here is a hands-on example that Oscar has lived through in practice: PrEP drugs. PrEP (pre-exposure prophylaxis for HIV) refers to medications taken by people at elevated risk of HIV infection; they are an incredible scientific feat, quite effective and can nearly eliminate HIV risk for adherent patients.
When the first drug came out, it was without alternative in preventing HIV infection. Many people meet standard guidelines for who is at risk (nearly 1 in 300, more than the number living with HIV), so as society, weād want this drug in as many hands as possible. But, it is very expensive. At about $1500/month in 2017, it was one of Oscarās most expensive drugs not subject to utilization management.
So we felt the very real tension of the dreaded āactuarial death spiralā on the one hand, and investing in membersā future on the other hand: by 2017 PrEP was our #1 drug, making up 6% of our total RX spend. Our younger-than-average population at that time made our exposure particularly high. In retrospect, we had about 15x the number of people taking PrEP as youād see in a random sample of Americans (see chart). In other words, we were helping keep a lot of people out of HIV harm's way, but it risked getting so expensive that the entire idea of it would just get priced out of the market, together with us. (1/3)
Alex Bisignano retweeted
The Enigma team got into a debate over who the best sci-fi author is. We have many more favorites, but whittled it down to four, what's your vote?
63%Isaac Asimov
9%Ursula le Guin
13%Robert Heinlein
15%William Gibson
86 votes ⢠Final results Alex Bisignano retweeted
Googleās Gemini issue is not really about woke/DEI, and everyone who is obsessing over it has failed to notice the much, MUCH bigger problem that it represents.
(1/n)
Alex Bisignano retweeted
Excited to announce that @ezrainc has raised $21 million in a round led by Amir Dan Rubin from Healthier Capital. Prior to starting Healthier Capital Amir was CEO of Amazon's One Medical, and is one of the most accomplished healthcare entrepreneurs in the US. The round was co-led by @rick from @FirstMarkCap.
We will be using the new funding to double down on our AI efforts and continue investing in our master plan - offering a 15-minute full body MRI priced at $500. We've recently had a number of AI breakthroughs that give me confidence we will get there within the next 2 to 3 years.
We've also added a number of incredible investors to the cap table - Allianz Life Ventures (venture arm of Allianz Insurance Group), the Schwarzman family, the former Chairman of Englandās NHS Lord David Prior, and a number of others (see full list in the blog post in the next tweet).
This year, 10 million people will be diagnosed with late-stage cancer. Our ambition at Ezra is to help all these individuals find cancer early, when it's most curable. It has been 5 years since I started the company, but it still feels like Day 1. Let's go!
Read the full announcement in the next tweet.
Alex Bisignano retweeted
Medicare Advantage (MA) is a total scam. Itās certainly not an advantage and would be more accurately called Medicare DISadvantage. Itās crazy to me that now over 50% of Medicare enrollees have switched over to Medicare Advantage plans run by profit seeking BUCAs.
1/4
medpagetoday.com/special-repā¦
Alex Bisignano retweeted
Amidst the Grail/illumina debacle, out pops this study. Though the paper doesnāt say it, Genomeweb reports that yeah, it could turn out to be a series of humble ELISAs that could do MCED š«¢ genomeweb.com/molecular-diagā¦
Alex Bisignano retweeted
There are 3 legs of the stool in health-tech, unless itās a consumer biz. Companies need expertise across:
ā Health ācareā / clinical
ā Health policy / reimbursement
ā Tech / engineering
We talk a lot about 1 & 3. Not enough about 2. ā at Queens, NY
Alex Bisignano retweeted
Immensely proud to share our four papers on #SingleCell dissection of #Alzheimers Disease coming out in @CellCellPress today, reporting 2.3M #scRNA profiles and 850k #scATAC profiles across 427 post-mortem human brain samples from AD and non-AD donors in a wonderful #interdisciplinary collaboration with @DrLiHueiTsai between @MIT @MIT_Picower @MIT_CSAIL @BroadInstitute @RushUniversity
Paper 1: scRNA + vulnerability + resilience cell.com/cell/fulltext/S0092ā¦
Paper 2: scATAC + GWAS + Epigenome Erosion cell.com/cell/fulltext/S0092ā¦
Paper 3: Microglia States + reprogramming cell.com/cell/fulltext/S0092ā¦
Paper 4: DNA damage + gene fusions cell.com/cell/fulltext/S0092ā¦
MIT News: news.mit.edu/2023/decoding-cā¦
Issue: cell.com/cell/current
News & Views: cell.com/cell/fulltext/S0092ā¦
Alex Bisignano retweeted
AI dazzled the public with its human-like responses, and developers with its emergent abilities. In spite of the hype, it hasn't changed your life yet. Why is that? And how to invest in an era of wizardry
medium.com/@jamesgettinger/aā¦
Alex Bisignano retweeted
Grateful to share our latest publication: Weāve previously shown age reversal is possible using gene therapy to turn on embryonic genes. Now we show itās possible with chemical cocktails, a step towards affordable whole-body rejuvenation 1/17 aging-us.com/article/204896/ā¦
Alex Bisignano retweeted
Shutting down AI development for six months gives the bad guys six more months to catch up. Our enemies are working hard to develop their own @OpenAI. It would have been a mistake to delay the Manhattan Project and let the Nazis catch up. I donāt think we have a choice.























